Mitchell, J. et al. — MAPP1 Phase 3 MDMA trial, Nature Medicine (2021)

First Phase 3 randomized controlled trial of MDMA-assisted therapy for severe PTSD published in Nature Medicine. Landmark clinical psychiatry research with significant effect sizes.